These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24966405)

  • 1. Neurofluctuation in patients with subcortical ischemic stroke.
    Vahidy FS; Hicks WJ; Acosta I; Hallevi H; Peng H; Pandurengan R; Gonzales NR; Barreto AD; Martin-Schild S; Wu TC; Rahbar MH; Bambhroliya AB; Grotta JC; Savitz SI
    Neurology; 2014 Jul; 83(5):398-405. PubMed ID: 24966405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks and Benefits Associated With Prestroke Antiplatelet Therapy Among Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator.
    Xian Y; Federspiel JJ; Grau-Sepulveda M; Hernandez AF; Schwamm LH; Bhatt DL; Smith EE; Reeves MJ; Thomas L; Webb L; Bettger JP; Laskowitz DT; Fonarow GC; Peterson ED
    JAMA Neurol; 2016 Jan; 73(1):50-9. PubMed ID: 26551916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperglycemia predicts unfavorable outcomes in acute ischemic stroke patients treated with intravenous thrombolysis among a Chinese population: A prospective cohort study.
    Lin SF; Chao AC; Hu HH; Lin RT; Chen CH; Chan L; Lin HJ; Sun Y; Lin YY; Chen PL; Lin SK; Sun MH; Wei CY; Lin YT; Lee JT; Bai CH;
    J Neurol Sci; 2018 May; 388():195-202. PubMed ID: 29627022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
    Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
    Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurologic deterioration in patients with acute ischemic stroke or transient ischemic attack.
    Park TH; Lee JK; Park MS; Park SS; Hong KS; Ryu WS; Kim DE; Park MS; Choi KH; Kim JT; Kang J; Kim BJ; Han MK; Lee J; Cha JK; Kim DH; Kim JG; Lee SJ; Cho YJ; Kwon JH; Shin DI; Yeo MJ; Sohn SI; Hong JH; Lee JS; Choi JC; Kim WJ; Lee BC; Yu KH; Oh MS; Park JM; Kang K; Lee KB; Lee J; Gorelick PB; Bae HJ
    Neurology; 2020 Oct; 95(16):e2178-e2191. PubMed ID: 32817184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Deterioration and Early Imaging Changes after Intravenous Tissue Plasminogen Activator Administration in Acute Ischemic Stroke Patients.
    Chou C; Bourekas EC; Slivka A
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1823-1827. PubMed ID: 27133771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclusion of ischemic stroke patients from intravenous tissue plasminogen activator treatment for mild symptoms should not be based on low National Institutes of Health Stroke Scale Scores.
    Wendt M; Tütüncü S; Fiebach JB; Scheitz JF; Audebert HJ; Nolte CH
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):550-3. PubMed ID: 23433783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
    Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
    J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke.
    Ma H; Campbell BCV; Parsons MW; Churilov L; Levi CR; Hsu C; Kleinig TJ; Wijeratne T; Curtze S; Dewey HM; Miteff F; Tsai CH; Lee JT; Phan TG; Mahant N; Sun MC; Krause M; Sturm J; Grimley R; Chen CH; Hu CJ; Wong AA; Field D; Sun Y; Barber PA; Sabet A; Jannes J; Jeng JS; Clissold B; Markus R; Lin CH; Lien LM; Bladin CF; Christensen S; Yassi N; Sharma G; Bivard A; Desmond PM; Yan B; Mitchell PJ; Thijs V; Carey L; Meretoja A; Davis SM; Donnan GA;
    N Engl J Med; 2019 May; 380(19):1795-1803. PubMed ID: 31067369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with intracerebral hemorrhage after thrombolytic therapy for ischemic stroke: pooled analysis of placebo data from the Stroke-Acute Ischemic NXY Treatment (SAINT) I and SAINT II Trials.
    Cucchiara B; Kasner SE; Tanne D; Levine SR; Demchuk A; Messe SR; Sansing L; Lees KR; Lyden P;
    Stroke; 2009 Sep; 40(9):3067-72. PubMed ID: 19608993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Tissue Plasminogen Activator Dosing on Patients Weighing More Than 100 kg on 3-Month Outcomes in Acute Ischemic Stroke.
    Garavaglia J; Sherman J; Yetzer H; Regier M; Smith M
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1041-1046. PubMed ID: 28129994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Too good to treat? Outcomes in patients not receiving thrombolysis due to mild deficits or rapidly improving symptoms.
    Willey JZ; Stillman J; Rivolta JA; Vieira J; Doyle MM; Linares G; Marchidann A; Elkind MS; Boden-Albala B; Marshall RS
    Int J Stroke; 2012 Apr; 7(3):202-6. PubMed ID: 22103880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility-weighted imaging for cerebral microbleed detection in super-acute ischemic stroke patients treated with intravenous thrombolysis.
    Bai Q; Zhao Z; Sui H; Xie X; Chen J; Yang J; Zhang L
    Neurol Res; 2013 Jul; 35(6):586-93. PubMed ID: 23561793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
    Chen J; Zhang Z; Chen L; Feng X; Hu W; Ge W; Li X; Jin P; Shao B
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2857-2862. PubMed ID: 30064868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanded Indication for Recombinant Tissue Plasminogen Activator from 3 to 4.5 h after Onset of Stroke in Japan.
    Miyamoto Y; Aso S; Iwagami M; Morita K; Fushimi K; Hamasaki Y; Nangaku M; Doi K; Yasunaga H
    J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105341. PubMed ID: 33039772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy with intravenous recombinant tissue plasminogen activator in Japanese older patients with acute ischemic stroke: Fukuoka Stroke Registry.
    Matsuo R; Kamouchi M; Ago T; Hata J; Shono Y; Kuroda J; Wakisaka Y; Sugimori H; Kitazono T;
    Geriatr Gerontol Int; 2014 Oct; 14(4):954-9. PubMed ID: 24320947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes.
    Tanahashi N; Yamaguchi T; Awano H; Matsuda H
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1302-1310. PubMed ID: 29373227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
    Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
    Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.